In the United States, most disposable medical masks are regulated by the FDA as medical devices, while respirators such as N95s are certified by the National Institute for Occupational Safety and Health (NIOSH). These regulatory frameworks establish testing standards for filtration, breathability, fluid resistance, and other performance characteristics.

However, manufacturers are generally not permitted to claim that a mask prevents infection or disease transmission. Instead, companies must describe measurable performance characteristics such as filtration efficiency or fluid resistance.

This means mask information often focuses on technical test results rather than direct statements about infection risk. Understanding how those performance measurements relate to real-world protection can help people make more informed decisions about mask use.

In the United States, medical masks are regulated by the U.S. Food and Drug Administration (FDA) as medical devices. The FDA reviews masks based on laboratory performance testing such as filtration efficiency, breathability, and fluid resistance. These laboratory tests form the basis of the FDA-cleared indications for use for a mask.

Because of this regulatory framework, mask manufacturers must ensure that their marketing and product descriptions remain consistent with the device’s FDA-cleared indications. Manufacturers are therefore generally not permitted to claim that a mask prevents infection or disease transmission, even if scientific evidence suggests that reducing exposure to virus-containing particles lowers infection risk. This is similar to other regulated medical products, where companies may only promote uses that have been specifically reviewed and cleared by the FDA.

Instead, mask performance is evaluated using standardized laboratory tests that measure how effectively the mask filters particles of specific sizes, how breathable the mask is, and how well it resists fluid penetration. These tests allow different masks to be compared under controlled conditions.

Studying infection outcomes directly is also difficult because infection risk depends on many factors beyond the mask itself, including exposure time, ventilation, distance from infected individuals, and the health or immunity of the person wearing the mask. For this reason, mask science generally focuses on measuring how well masks reduce exposure to virus-containing particles, which is the mechanism by which masks help reduce infection risk.

The CDC generally provides guidance about masks in terms of relative protection and general categories, rather than absolute rankings between specific mask designs. Their guidance emphasizes that masks and respirators can help reduce the spread of respiratory viruses by capturing droplets and aerosols before they are inhaled.

Respirators such as N95s are designed to provide very high filtration and are intended to form a tight seal against the face when properly fitted, which is why they are commonly used in occupational settings. At the same time, the CDC notes that well-fitting medical masks can also reduce exposure to virus-containing particles.

Importantly, the CDC also emphasizes that protection depends on more than filtration alone. Factors such as how well a mask fits the face, how breathable and comfortable it is to wear, and whether it is worn consistently all influence how effective a mask will be in real-world settings.

For this reason, the level of protection a mask provides can vary depending on the situation and the individual wearer. Selecting the most appropriate mask often involves balancing filtration performance, fit, comfort, and consistent use.

Comparisons between masks are often made using laboratory filtration tests, which measure how effectively a mask filters particles under controlled conditions. While these tests are important for understanding mask performance, they do not always reflect how masks perform in real-world environments where factors such as fit, comfort, ventilation, and duration of exposure also influence infection risk.

Side-by-side laboratory comparisons can sometimes give a misleading sense of practical importance. For example, a cyclist might spend hundreds of dollars to reduce the weight of a component by one ounce, which improves a specification on paper but may not translate into meaningful real-world performance. In a similar way, N95 respirators often achieve higher filtration ratings in laboratory tests, but the more important question is whether those differences lead to lower infection rates in real-world settings.

Several large clinical studies have attempted to answer that question. One widely cited randomized clinical trial published in Annals of Internal Medicine (2022) by Conly et al. compared healthcare workers wearing N95 respirators with those wearing medical masks while caring for patients in hospital settings across multiple countries. The study followed thousands of healthcare workers and measured laboratory-confirmed COVID-19 infection.

The investigators concluded that medical masks were non-inferior to N95 respirators for preventing COVID-19 infection among participating healthcare workers in the settings studied. In other words, the study did not find a statistically significant difference in infection rates between the two groups.

It is important to note that the study evaluated conventional medical masks and respirators and did not assess masks incorporating additional technologies such as antiviral materials designed to inactivate viruses after capture.

These findings highlight that laboratory filtration performance is only one part of the picture. Real-world protection depends on a combination of factors including filtration performance, fit, breathability, exposure duration, and whether a mask can be worn comfortably and consistently.